Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01094808 · ClinicalTrials.gov registry record · Phase 4
Pregabalin and Colonic Function
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT01094808: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT01094808 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01094808, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
This study is being done to evaluate the effects of pregabalin, a drug approved for anticonvulsive therapy and for neuropathic pain, on colonic and sensory functions in healthy individuals. The specific study hypotheses were as follows: 1) pregabalin increases sensation thresholds, decreases sensation ratings, and increases compliance in response to balloon distension in the colon; 2) pregabalin reduces colonic phasic and tonic motility in response to a standardized meal; and 3) sensation ratings are lower with higher colonic compliance.
Interventions
- DRUG Placebo
- DRUG Pregabalin
- OTHER Bowel preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01094808
The ClinicalTrials.gov registry entry for NCT01094808 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01094808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01094808 about?
NCT01094808 is a clinical study titled "Pregabalin and Colonic Function". This study is being done to evaluate the effects of pregabalin, a drug approved for anticonvulsive therapy and for neuropathic pain, on colonic and sensory functions in healthy individuals. The specific study hypotheses were as follows: 1) pregabalin increases sensation thresholds, decreases sensat...
What is the current status of trial NCT01094808?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2010-03. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01094808?
The interventions under investigation include: Placebo (DRUG), Pregabalin (DRUG), Bowel preparation (OTHER).
Who is sponsoring clinical trial NCT01094808?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.